Galapagos N.V. Company Profile | StatInvestor

Health Care & Life Sciences » Biotechnology | Galapagos

Galapagos

Galapagos N.V.
Stock Exchange	Other OTC
EPS	$0.89
Market Cap	$7.48 B
Shares Outstanding	51.23 M
Public Float	-

Galapagos N.V.
Stock Exchange	Euronext - Alternext Amsterdam
EPS	EUR0.77
Market Cap	EUR6.67 B
Shares Outstanding	54.82 M
Public Float	41.56 M

Galapagos N.V.
Stock Exchange	Frankfurt Stock Exchange
EPS	-
Market Cap	-
Shares Outstanding	51.34 M
Public Float	-

Galapagos N.V. ADR
Stock Exchange	NASDAQ Stock Market
EPS	$0.89
Market Cap	$7.4 B
Shares Outstanding	54.82 M
Public Float	54.38 M

Profile

Address	Industriepark Mechelen Noord Mechelen BU 2800 Belgium
Employees	-
Website	http://www.glpg.com
Updated	07/08/2019
Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. It operates through the Research and Development and Fee-for-Services segment. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.

Financials

Raj B. Parekh

Chairman

Onno van de Stolpe

Chief Executive Officer & Executive Director